Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Marks and Clerk
Marks and Clerk
Activities:
Finance
Patient Experience
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Life sciences sector hit with funding cuts, but novel report highlights feasible industry solutions
The review highlights the recent investment reductions observed within the life sciences industry, and why its important to support smaller businesses to develop their innovations
Sanofi and Novavax co-commercialise COVID-19 vaccine
The agreement will aim to commercialise Novavax's adjuvanted COVID-19 vaccination globally, as well as develop a COVID-19 and flu combination vaccine
Realtime flowmeters provide full software connectivity to HPLC data system
The RC.net/ICF compatible software allows users to gather accurate and precise flow readings while using chromatography software packages
WestGene's mRNA therapeutic cancer vaccine receives FDA approval
The novel mRNA therapeutic is the first EB virus-related cancer vaccine to be approved by the FDA
Upcoming event
BIO International Convention Digital
3-6 June, 2024 | Convention | San Diego, US
See all
Related Content
Ingredients
Taking a multifaceted approach to combatting superbugs
Paul Chapman, Partner at Marks & Clerk LLP, takes a look at research underway for testing a compound on Gram-negative bacteria known for being the most difficult to treat of all infections
Research & Development
UK pharmaceutical patents up 20%
Innovation seen to be key as this sector continues to grow and export its technology to the wider world, reports Marks & Clerk
Finance
UK pharma and biotech patent filings surge, investor confidence sign?
The European Patent Office has reported a surge in pharmaceutical and biotechnology patents – potentially a sign of growing investor confidence in these sectors, according to IP firm Marks & Clerk
Patient Experience
Rare disease patent filings on the rise, finds report, but antibiotics may lose another decade
Research into new antibiotic classes represents less than 5% of antibiotics-related patent filings
Patient Experience
US changes its patent laws
America Invents Act replaces first-to-invent system with first-to-file system
Regulatory
Parliament approves EU unitary patent rules
Patent package includes the unitary patent, language regime and unified patent court
Regulatory
EU moves a step closer to establishing a unitary patent
EU patent protection expected to become less expensive, simpler and more efficient
Subscribe now